Stocks · US
ABBV
XNYS
ABBVIE INC.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E74.66x
P/B—
P/S7.29x
EPS$3.56
ROE-105.98%
ROA4.66%
Dividend yield2.55%
EV/EBITDA18.10x
Debt/Equity-11.93
Free cash flow$18.2B
Returns and 52-week range
1W+1.29%
1M+3.99%
3M+5.52%
6M+29.23%
1Y+14.01%
YTD+16.30%
52W high$269.39
52W low$190.75
From 52W high-1.00%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 존슨 앤드 존슨 | $609.5B | 28.97 | 7.17 | -7.43% |
| 머크 | $344.3B | 108.50 | 8.21 | -5.58% |
| 유나이티드헬스 그룹 | $339.8B | 24.06 | 3.45 | -5.24% |
| 노바티스(ADR) | $267.9B | 39.64 | 3.70 | -12.00% |
| 써모 피셔 사이언티픽 | $250.2B | 35.92 | 4.75 | +6.97% |
| 아스트라제네카 | $242.8B | 109.30 | 17.94 | -2.51% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.